Yes it was a good entry point .. that's why I'm blaming myself I missed it .. As they already made capital raising, I believe it's yes still cheap .. Thanks Grace
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025